A revolutionary study by Case Western Reserve University researchers reveals that a class of medications used to treat type 2 diabetes may also lower the risk of colorectal cancer (CRC).
News Today | First with the news
News Today | First with the news
A revolutionary study by Case Western Reserve University researchers reveals that a class of medications used to treat type 2 diabetes may also lower the risk of colorectal cancer (CRC).